Delivery Order SPE2DB20D1051-SPE2DB24FD6CV
- Not listed
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,074.11. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $2,208.75. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets in quantities of 30 per package. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,662.24 and an ultimate completion date of March 7, 2024. The contract was awarded on March 6, 2024 and is a firm fixed-price delivery order. The contract does...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs. The contract, valued at $5,522.85, is a delivery order with a firm fixed price and an ultimate completion date of November 2, 2021. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The $4,767.14 delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 1, 2023 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Telmisartan 80 mg tablets, with a ceiling value of $1,763.27 and a final completion date of June 9, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Telmisartan 80 mg Tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,387.21, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order with a Firm Fixed Price, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The $22,388.68 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 7, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a firm fixed price of $1,044.00 and a completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award is for the delivery of telmisartan 40 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price contract is valued at $1,871.31 and has an ultimate completion date of November 22, 2024. It was awarded on November 21, 2024 as a delivery order, without any set-aside designation. AmerisourceBergen holds a significant $999,999,999...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD6CVDelivery Order
This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,610.96 and an ultimate completion date of November 27, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract was awarded on November 24, 2023, and does not have a set-aside designation, indicating it was a full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/24/23 |